Zim Laboratories Ltd
Zim Laboratories is engaged in the manufacturing of formulation drugs and pre formulation ingredients in India and marketing and selling these within and outside India.
- Market Cap ₹ 138 Cr.
- Current Price ₹ 85.0
- High / Low ₹ 131 / 42.0
- Stock P/E 14.4
- Book Value ₹ 97.2
- Dividend Yield 0.00 %
- ROCE 5.39 %
- ROE 2.17 %
- Face Value ₹ 10.0
Pros
- Stock is trading at 0.87 times its book value
Cons
- Promoter holding is low: 33.26%
- Tax rate seems low
- Company has a low return on equity of 8.01% for last 3 years.
- Dividend payout has been low at 3.16% of profits over last 3 years
- Company's cost of borrowing seems high
Peer comparison
Sector: Pharmaceuticals Industry: Pharmaceuticals - Indian - Formulations
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Mar 2018 | Jun 2018 | Sep 2018 | Dec 2018 | Mar 2019 | Jun 2019 | Sep 2019 | Dec 2019 | Mar 2020 | Jun 2020 | Sep 2020 | Dec 2020 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
71.50 | 71.05 | 71.67 | 98.05 | 94.59 | 67.41 | 67.79 | 73.35 | 69.20 | 70.48 | 88.03 | 74.91 | |
62.39 | 62.22 | 61.33 | 85.43 | 84.35 | 64.30 | 63.20 | 65.34 | 62.29 | 59.91 | 75.34 | 67.36 | |
Operating Profit | 9.11 | 8.83 | 10.34 | 12.62 | 10.24 | 3.11 | 4.59 | 8.01 | 6.91 | 10.57 | 12.69 | 7.55 |
OPM % | 12.74% | 12.43% | 14.43% | 12.87% | 10.83% | 4.61% | 6.77% | 10.92% | 9.99% | 15.00% | 14.42% | 10.08% |
Other Income | 7.44 | 0.34 | 0.19 | 0.72 | 0.80 | 1.05 | 0.42 | 0.61 | 2.43 | 0.62 | -4.99 | 0.70 |
Interest | 2.94 | 2.63 | 2.97 | 2.51 | 2.48 | 3.24 | 3.17 | 3.23 | 3.01 | 2.94 | 2.67 | 2.36 |
Depreciation | 2.61 | 2.59 | 2.85 | 2.76 | 3.23 | 3.36 | 3.45 | 3.74 | 3.86 | 3.85 | 3.84 | 3.91 |
Profit before tax | 11.00 | 3.95 | 4.71 | 8.07 | 5.33 | -2.44 | -1.61 | 1.65 | 2.47 | 4.40 | 1.19 | 1.98 |
Tax % | 29.09% | 4.05% | 28.87% | 27.01% | 56.85% | 103.28% | 62.73% | 7.27% | 6.88% | 25.23% | 0.84% | 34.85% |
Net Profit | 7.79 | 3.79 | 3.35 | 5.89 | 2.30 | 0.09 | -0.61 | 1.52 | 2.30 | 3.28 | 1.19 | 1.29 |
EPS in Rs | 2.35 | 2.08 | 3.65 | 1.43 | 0.06 | -0.38 | 0.94 | 1.42 | 2.03 | 0.73 | 0.79 | |
Notes | Notes | Notes | Notes | Notes | Notes | Notes | Notes | Notes | Notes | Notes | Notes |
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | TTM | |
---|---|---|---|---|---|---|
269 | 235 | 273 | 335 | 278 | 303 | |
239 | 203 | 238 | 293 | 255 | 265 | |
Operating Profit | 30 | 32 | 35 | 42 | 23 | 38 |
OPM % | 11% | 13% | 13% | 13% | 8% | 12% |
Other Income | -2 | 5 | 9 | 2 | 5 | -1 |
Interest | 14 | 10 | 9 | 11 | 13 | 11 |
Depreciation | 9 | 9 | 10 | 11 | 14 | 15 |
Profit before tax | 5 | 18 | 25 | 22 | 0 | 10 |
Tax % | 5% | -6% | 23% | 30% | -4,600% | |
Net Profit | 5 | 19 | 19 | 15 | 3 | 8 |
EPS in Rs | 9.52 | 2.04 | 4.97 | |||
Dividend Payout % | 16% | 4% | 4% | 5% | 0% |
Compounded Sales Growth | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | 6% |
TTM: | -0% |
Compounded Profit Growth | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | -44% |
TTM: | 190% |
Stock Price CAGR | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | % |
1 Year: | 34% |
Return on Equity | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | 8% |
Last Year: | 2% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Sep 2020 | |
---|---|---|---|---|---|---|
8 | 8 | 8 | 16 | 16 | 16 | |
Reserves | 91 | 110 | 129 | 135 | 138 | 142 |
Borrowings | 96 | 81 | 81 | 77 | 90 | 65 |
61 | 60 | 81 | 100 | 82 | 106 | |
Total Liabilities | 256 | 259 | 298 | 328 | 325 | 329 |
92 | 89 | 94 | 106 | 116 | 115 | |
CWIP | 3 | 4 | 8 | 13 | 10 | 5 |
Investments | 0 | 0 | 0 | 0 | 0 | 0 |
161 | 166 | 196 | 209 | 200 | 209 | |
Total Assets | 256 | 259 | 298 | 328 | 325 | 329 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | |
---|---|---|---|---|---|
22 | 32 | 37 | 35 | 22 | |
-12 | -7 | -26 | -21 | -18 | |
-10 | -25 | -10 | -15 | -3 | |
Net Cash Flow | -0 | -0 | 1 | -1 | 1 |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | |
---|---|---|---|---|---|
ROCE % | 14% | 14% | 15% | 5% | |
Debtor Days | 120 | 137 | 119 | 101 | 89 |
Inventory Turnover | 3.42 | 3.37 | 3.13 | 2.70 |
Documents
Add documentRecent announcements
- Announcement under Regulation 30 (LODR)-Newspaper Publication 12 Feb
- Results - Financial Results For Quarter And Nine Months Ended 31.12.2020. 11 Feb
- Outcome Of Board Meeting Held On 11.02.2021 11 Feb
- Announcement under Regulation 30 (LODR)-Newspaper Publication 6 Feb
- Board Meeting Intimation for Consideration And Approval Of Unaudited Financial Results (Standalone And Consolidated) Of The Company For The Quarter And Nine Month Ended 31St December, 2020. 5 Feb
View all